ipratropium

简明释义

英[ɪpˈrætrəpiəm]美[ɪpˈrætroʊpiəm]

异丙托铵（支气管扩张药）

英英释义

单词用法

同义词

反义词

例句

1.AIM: To observe the effect of fenoterol and ipratropium bromide alone or combined in the treatment of childhood acute paroxysm of asthma.

目的：观察非诺特罗、异丙托溴铵单用及联合用药治疗小儿哮喘急性发作的疗效。

2.Objective To investigate the effective and safety of nebulized budesonide suspension plus Albuterol and ipratropium bromide inhaled in treatment of attack of asthma in children.

目的评价布地奈德雾化悬浊液联合复方异丙托溴铵溶液治疗儿童哮喘急性发作的临床疗效。

3.Objective to observe the effect of inhaled ipratropium bromide on airway and lung tissue muscarinic receptors (MR) in a rat model of chronic obstructive pulmonary disease (COPD).

目的观察吸入溴化异丙托品对大鼠慢性阻塞性肺疾病(COPD)模型气道和肺组织m受体的影响及其规律。

4.Significant decrease in the number of tracheal epithelia goblet cells, secretion of mucin were observed in ipratropium bromide and atropine treated rats.

溴化异丙托品和阿托品都显著减少气管上皮杯状细胞数目及粘蛋白的分泌。

5.Objective: To observe the therapeutic efficacy of nebulized budesonide suspension plus albuterol and ipratropium bromide in childhood asthma.

目的：观察布地奈德混悬液联合沙丁胺醇、溴化异丙托品雾化吸入治疗哮喘的效果。

6.Objective to observe the effect of inhaled ipratropium bromide on airway and lung tissue muscarinic receptors (MR) in a rat model of chronic obstructive pulmonary disease (COPD).

目的观察吸入溴化异丙托品对大鼠慢性阻塞性肺疾病(COPD)模型气道和肺组织m受体的影响及其规律。

7.Try topical nasal steroid preparation or intranasal ipratropium bromide before bedtime.

尝试局部类固醇鼻准备或鼻内异丙托溴铵睡前。

8.MethodsCompared the treatment of the oxygen-driven ipratropium bromide nebulization with mask oxygen inhalation devices and traditional oxygen with nasal catheter.

方法氧气雾化吸入器面罩吸入异丙托溴铵与传统鼻塞吸氧方法进行比较。

9.Conclusion: Atomization inhalation with ipratropium bromide or salbutamol is more effective than aminophylline in treatment of asthmatic diseases in children.

结论：爱喘乐、喘乐宁雾化吸入治疗小儿喘息性疾病有显著疗效。

10.Aim To investigate the effect and safety of nebulized budesonide suspension plus albuterol and ipratropium bromide inhaled in treatment of attack of asthma in children.

目的评价布地奈德雾化悬浊液联合复方异丙托溴铵溶液治疗儿童哮喘急性发作的临床疗效。

11.Patients are advised to use ipratropium via an inhaler for best results.

建议患者通过吸入器使用异丙托溴铵以获得最佳效果。

12.The doctor prescribed ipratropium for the patient suffering from chronic obstructive pulmonary disease.

医生为患有慢性阻塞性肺病的患者开了异丙托溴铵。

13.Using ipratropium can help relieve bronchospasm during asthma attacks.

使用异丙托溴铵可以帮助缓解哮喘发作期间的支气管痉挛。

14.In clinical trials, ipratropium showed significant improvements in lung function.

在临床试验中，异丙托溴铵显示出肺功能的显著改善。

15.Side effects of ipratropium may include dry mouth and dizziness.

使用异丙托溴铵的副作用可能包括口干和头晕。

作文

The use of medication in managing respiratory conditions has evolved significantly over the years. One such medication that has gained prominence is ipratropium, which is often used to treat chronic obstructive pulmonary disease (COPD) and asthma. Understanding how ipratropium works can help patients manage their symptoms effectively and improve their quality of life. ipratropium is an anticholinergic bronchodilator that acts by blocking the action of acetylcholine on muscarinic receptors in the bronchial smooth muscle. This action leads to the relaxation of the airways, allowing for easier airflow and improved breathing. Patients suffering from COPD or asthma often experience bronchoconstriction, which is the tightening of the muscles around the airways. By using ipratropium, they can alleviate this symptom and reduce the frequency of exacerbations. One of the key benefits of ipratropium is its rapid onset of action. Patients typically feel relief within minutes after inhalation, making it a valuable rescue medication during acute episodes of shortness of breath. Additionally, ipratropium can be used in combination with other medications, such as beta-agonists, to enhance its bronchodilatory effects. This combination therapy can provide a more comprehensive approach to managing respiratory conditions. Furthermore, ipratropium is generally well-tolerated by most patients. Common side effects may include dry mouth, throat irritation, and headache, but these are usually mild and temporary. It is essential for patients to discuss any concerns with their healthcare provider, especially if they have pre-existing conditions or are taking other medications. In recent years, studies have explored the long-term effects of using ipratropium for chronic management of respiratory diseases. Research indicates that regular use of ipratropium can lead to improved lung function and a decrease in the number of exacerbations, ultimately enhancing patients' overall health status. This makes it an important consideration for individuals seeking to manage their conditions effectively. In conclusion, ipratropium plays a crucial role in the management of respiratory diseases like COPD and asthma. Its ability to provide quick relief from bronchoconstriction and its compatibility with other medications make it a valuable tool in respiratory therapy. Patients should work closely with their healthcare providers to determine the best treatment plan that includes ipratropium to ensure optimal management of their condition. With proper understanding and use of this medication, patients can lead healthier, more active lives despite their respiratory challenges.

ipratropium的使用在管理呼吸系统疾病方面已经有了显著的进展。这种药物在慢性阻塞性肺病（COPD）和哮喘的治疗中越来越受到重视。了解ipratropium的作用机制可以帮助患者有效管理症状，提高生活质量。ipratropium是一种抗胆碱能支气管扩张剂，通过阻断乙酰胆碱在支气管平滑肌的毒蕴受体上的作用来发挥作用。这一作用导致气道放松，从而使气流更加顺畅，呼吸更加轻松。患有COPD或哮喘的患者常常会经历支气管收缩，即围绕气道的肌肉紧绷。通过使用ipratropium，他们可以缓解这一症状，并减少急性发作的频率。ipratropium的一个主要好处是其快速起效。患者通常在吸入后几分钟内就能感到缓解，这使其成为急性呼吸困难发作期间的宝贵救助药物。此外，ipratropium可以与其他药物（如β激动剂）联合使用，以增强其支气管扩张效果。这种联合治疗可以为管理呼吸系统疾病提供更全面的方案。此外，ipratropium通常被大多数患者良好耐受。常见的副作用可能包括口干、喉咙刺激和头痛，但这些通常是轻微和暂时的。患者在使用此药物时，特别是如果有既往疾病或正在服用其他药物时，务必与医疗提供者讨论任何顾虑。近年来，研究探讨了长期使用ipratropium进行慢性呼吸系统疾病管理的效果。研究表明，定期使用ipratropium可以改善肺功能，并减少急性发作的次数，最终提高患者的整体健康状况。这使得它成为希望有效管理自己疾病的个体需要考虑的重要因素。总之，ipratropium在管理COPD和哮喘等呼吸系统疾病中发挥着至关重要的作用。它能够快速缓解支气管收缩，并且与其他药物的兼容性，使其成为呼吸治疗中的重要工具。患者应与医疗提供者密切合作，确定最佳的治疗方案，其中包括ipratropium，以确保对其病情的最佳管理。通过对该药物的正确理解和使用，患者可以在面对呼吸挑战时过上更健康、更积极的生活。